BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34592766)

  • 1. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
    Kawasaki T; Ooka S; Mizushima M; Nakamura Y; Ikeda H; Sakurada T; Suzuki S; Yamazaki K; Goto Y; Sakurai K; Yukitaka Y; Kiyokawa T; Tonooka K; Kunishima H; Kawahata K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):101-105. PubMed ID: 34592766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
    Yamabe T; Ohmura SI; Uehara K; Naniwa T
    Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
    Horiuchi Y; Hashimoto K; Horikoshi H; Sano A; Kawamura Y; Fujita N; Kimata M; Ono Y; Obuchi Y; Makino A; Kaneko M; Kimura F; Itoh K; Tanaka Y
    Medicine (Baltimore); 2022 Jul; 101(28):e29354. PubMed ID: 35839054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
    Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
    Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
    Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
    Bindoli S; Galozzi P; Doria A; Sfriso P
    Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
    Ruscitti P; Di Cola I; Di Muzio C; Italiano N; Ursini F; Giacomelli R; Cipriani P
    Autoimmun Rev; 2022 Jul; 21(7):103114. PubMed ID: 35595050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.
    Rosário C; Zandman-Goddard G; Meyron-Holtz EG; D'Cruz DP; Shoenfeld Y
    BMC Med; 2013 Aug; 11():185. PubMed ID: 23968282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
    Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still's disease.
    Souabni L; Dridi L; Ben Abdelghani K; Kassab S; Chekili S; Laater A; Zakraoui L
    Pan Afr Med J; 2014; 17():94. PubMed ID: 25018831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Suzuki S; Kataoka Y; Otani T; Taniguchi Y; Ikeda K; Tamura N; Morimoto S
    Clin Rheumatol; 2024 Mar; 43(3):1245-1251. PubMed ID: 38342797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
    Goda K; Kenzaka T; Hoshijima M; Yachie A; Akita H
    Rheumatol Int; 2020 Jan; 40(1):145-152. PubMed ID: 31541282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
    Sakai R; Nagasawa H; Nishi E; Okuyama A; Takei H; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Ito T; Kameda H; Takeuchi T; Amano K
    Clin Rheumatol; 2012 Mar; 31(3):569-74. PubMed ID: 22215118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
    Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
    Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of recurrence of adult-onset Still's disease in the third trimester: a case report and literature review.
    Hosoya S; Sadatsuki M; Izuka S; Yamashita H; Oishi H
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):163. PubMed ID: 33627085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab.
    Imaizumi C; Saito M; Abe F; Kaga H; Saito A; Nara M; Kameyama S; Miura H; Ogasawara H; Hirakawa T; Mizunuma M; Satoh M; Komatsuda A; Terada Y; Takahashi N
    Intern Med; 2022 Oct; 61(20):3137-3140. PubMed ID: 35283384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.